Requisition ID: OUT000583 MSD is a global health care leader with a diversified portfolio of prescription medicines, vaccines and animal health products. The difference between potential and achievement lies in the spark that fuels innovation and inventiveness; this is the space where MSD has codified its 125:year legacy. MSD's success is backed by ethical integrity, forward momentum, and an inspiring mission to achieve new milestones in global healthcare.
MSD is on a quest for cures and is committed to being the world's premier, most research:intensive biopharmaceutical company. Today, we're doubling down on this goal. MRL is a true scientific research facility of tomorrow, and will take MSD's leading discovery capabilities and world:class small molecule and biologics R and D expertise to create breakthrough science that radically changes the way we approach serious diseases.
The incumbent will join the CORE (Center for Observational and Real:world Evidence) Latin America (LATAM) region International team and focus in the area of Primary Care, Hospital, and Specialty products. Under the guidance of the CORE LATAM Lead, the incumbent will have the responsibility of supporting the interpretation and translation of CORE integrated evidence strategies for Primary Care, Hospital, and Specialty products developed at the global level to our company affiliates in the Latin America region. The scope of this support will include Health Technology Assessment (HTA)/ reimbursement dossier submission and overall Real World Evidence (RWE) activities that tailor these global strategies to the country strategies in the region. This process includes tight alignment with the CORE Primary Care, Hospital, and Specialty groups regarding strategy and plans, as well as having a high:level awareness of the setting and challenges in the LATAM countries. A close collaboration with regional above:markets teams (including Medical Affairs, Access and Pricing, and Policy) is required to ensure consistency and alignment with strategies. Another focus of the incumbent will be to collaborate with key markets to identify evidence gaps as well as how to support the value discussion, and address these from the Health Economic and Outcomes Research (HEOR) perspective, including supporting development of meaningful tools and arguments to guide discussion and interaction with Primary Care, Hospital, and Specialty stakeholders, payers, health systems and clinicians at country level.
The role involves interactions with our company country affiliates to have an understanding of country:specific HTA/reimbursement needs and to support timely and efficient HTA/reimbursement submission, including support country:specific adaptation of the global cost:effectiveness (CE) and budget impact (BI) models in LATAM.
The incumbent should be able to work with local teams around HEOR strategy and support and train the teams in relation to local HEOR and Local Data Generation (LDG) study execution. Another important element is to support our company colleagues as well as local thought leaders/researchers to understand and utilize evidence in the areas of HTA, HEOR and RWE, enabling them to make correct interpretations of HEOR studies as well as how to interpret CE and BI analysis for Primary Care, Hospital, and Specialty health policy decision:making at various levels in healthcare systems.
This position will focus in Primary Care (particularly diabetes), Hospital (particularly antibiotics), and Specialty (particularly HIV products).
This position could be based in any Latin America country; does not include relocation assistance.
Qualifications
Requirements:
:
A professional degree and an advanced degree at the Master's level from a school of medicine, in public health, management, pharmacy, or economics.
:
Work experience in health economics, epidemiology, outcomes research, health services research, p
